Study of Tirzepatide for Recovery and Alcohol Use Management

Summary

This is a pilot, 4-week, double-blind, placebo-controlled, randomized trial of individuals with alcohol use disorder (AUD) to receive weekly injections of either tirzepatide (n=10) or matching placebo (n=10). The primary aim is to determine the effects of tirzepatide on cue-reactivity among individuals with AUD. The secondary aim is to assess the safety and preliminary efficacy of tirzepatide for AUD.

Timeline

Start

2025-09-15

Primary completion

2027-03-01

Completion

2027-07-01

Drugs

Indications